+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing Trends: Scandinavia-Oncology

  • ID: 4861666
  • Report
  • September 2019
  • Region: Global
  • 63 pages
  • FinGlobe, Inc

FEATURED COMPANIES

  • 2cureX AB
  • Dignitana AB
  • Immunovia AB
  • Oncoinvent AS
  • RaySearch Laboratories AB
  • Targovax ASA
  • MORE

This trends report provides comprehensive analysis on all licensing deals and negotiations reported for the healthcare companies of Scandinavia in the Oncology medicine group during January 1, 2019 to August 31, 2019, categorized and summarized by various important aspects such as healthcare sub-sectors, market capitalization groups, across key regions, licensing payment arrangements and worldwide vs domestic licensing. Such detailed analysis helps to understand the licensing trends and directions during this time period in the healthcare segment of Scandinavia for the Oncology medicine group.

Analytical data coverage:

  • January 1, 2019 to August 31, 2019 licensing deals and negotiations
  • 60+ healthcare licensing news for Scandinavian companies (40+) in the Oncology medicine group
  • Small-mid-large cap companies covered-LargeCap (11%), SmallCap (15%)
  • Listed and non-listed companies included
  • 4 healthcare sub-sectors covered-Pharmaceuticals (19%), Biotech (30%), Medical Devices (25.5%), Healthcare Services (25.5%)
  • 8+ variables analyzed

Key Features:

  • 8 months’ healthcare licensing transactions of Scandinavia in the Oncology medicine group analyzed at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing details
  • Licensing trends and directions summarized

The Report is useful to:

  • Healthcare companies of Scandinavia planning to introduce products in other countries in the Oncology medicine group
  • Companies active in R&D and seeking new market base
  • Healthcare company executives of Scandinavia negotiating licensing deals in the Oncology medicine group
  • Investors analyzing varied kinds of transaction options for licensing deals in Scandinavia in the Oncology medicine group

Key analysis provided: January-August 2019

  • Total number of licensing deals signed by the Scandinavian companies in Oncology medicine group
  • Total number of Scandinavian companies involved in the licensing deals in Oncology medicine group
  • Most licensing deals signed by which of the Scandinavian countries
  • Most licensing deals signed by which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Licensing payment arrangements most followed in the licensing deals
  • Number of domestic and worldwide licensing
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 2cureX AB
  • Dignitana AB
  • Immunovia AB
  • Oncoinvent AS
  • RaySearch Laboratories AB
  • Targovax ASA
  • MORE
Introduction
Research Design

Chapter 1: Analysis of healthcare inventions of Scandinavia in the Oncology medicine group licensed during last eight months
1.1 Countries with most licensing deals
1.2 Healthcare sub-sectors with most licensing deals
1.3 Market capitalization groups with most licensing deals
1.4 Licensing payment arrangements most followed
1.5 Worldwide licensing vs domestic licensing

Chapter 2: Analysis of licensing deals of Scandinavia in the Oncology medicine group by key attributes during last eight months
2.1 For each of the countries
2.2 For each of the healthcare sub-sectors
2.3 For each of the marketcap groups
2.4 Across each of the regions

Chapter 3: Summary and conclusions

Appendices
Appendix 1 Healthcare inventions licensed for Scandinavia in the Oncology medicine group during last eight months - By company name
Appendix 2 List of companies/institutes covered - By country and company name
Appendix 3 List of companies/institutes covered - By sub-industry and company name
Appendix 4 List of companies/institutes covered - By market capitalization group and company name
Appendix 5 List of non-listed companies covered - By country and company name
Appendix 6 List of not-for-profit groups covered - By country and institute name
Appendix 7 List of companies/institutes covered - By terms of payment and company name
Appendix 8 Licensing deals discontinued for Scandinavia in the Oncology medicine group during last eight months
Note: Product cover images may vary from those shown
  • 2cureX AB
  • Alligator Bioscience AB
  • AroCell AB
  • Beactica AB
  • Belina Pharma AB
  • BioInvent International AB
  • Biovica International AB (publ)
  • Clinical Laserthermia Systems AB
  • C-Rad AB
  • Danish Breast Cancer Cooperative Group
  • Dignitana AB
  • Elekta AB
  • Elekta Instrument AB
  • Genagon Therapeutics AB
  • Genmab A/S
  • Haukeland University Hospital
  • Herantis Pharma Plc
  • Immunovia AB
  • Institute of Energy Technology
  • Karolinska Institutet
  • Karolinska University Hospital
  • Lidds AB
  • Lokon Pharma AB
  • Nordic Nanovector ASA
  • OncoImmunity AS
  • Oncoinvent AS
  • Oncology Venture A/S
  • Orion Corporation
  • Oslo University Hospital
  • Paxman AB
  • PledPharma AB
  • RaySearch Laboratories AB
  • Scandinavian ChemoTech AB
  • Scandion Oncology A/S
  • Sectra AB
  • Skandionkliniken
  • Solural Pharma ApS
  • Swedish Orphan Biovitrum AB
  • Targovax ASA
  • TILT Biotherapeutics Ltd
  • University Hospital Bispebjerg
  • University of Copenhagen
  • University of Oslo
  • Uppsala University Hospital
  • VibroSense Dynamics AB
  • Zealand University Hospital
  • Zelluna Immunotherapy AS
Note: Product cover images may vary from those shown
Adroll
adroll